selected publications
-
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.
PEC innovation.
2023
Academic Article
GET IT
Times cited: 5 - What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing. Cancer. 2022 Academic Article GET IT
- Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?. Familial cancer. 2022 Academic Article GET IT
- Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Review GET IT
-
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 22